Skip to main content Accessibility help
×
Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T11:07:48.639Z Has data issue: false hasContentIssue false

Case 24 - “This Is Humiliating”

Clozapine

Published online by Cambridge University Press:  31 October 2024

Matthew Gibfried
Affiliation:
Saint Louis University School of Medicine, Missouri
George T. Grossberg
Affiliation:
Saint Louis University School of Medicine, Missouri
Get access

Summary

Clozapine is now an important medication in the treatment of schizophrenia. It is used primarily in cases of treatment-resistant schizophrenia but is also useful in patients with schizophrenia that have had adverse effects to multiple other antipsychotics. The use of clozapine in schizophrenia has several benefits in addition to improving the control of the symptoms of schizophrenia for those with treatment-resistant schizophrenia. The risks of using clozapine are well known and the most feared side effect of clozapine is agranulocytosis. Agranulocytosis risk is highest in the first three months of use of the drug but is possible even after years of use. There are some off-label uses of clozapine that healthcare providers in long-term care should be aware of. Some studies have suggested that clozapine may be effective in treating treatment-resistant depression. Clozapine has been used off-label in the treatment of bipolar disorder, particularly in people who have not responded to other more commonly prescribed medications.

Information

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • “This Is Humiliating”
  • Matthew Gibfried, Saint Louis University School of Medicine, Missouri, George T. Grossberg, Saint Louis University School of Medicine, Missouri
  • Book: Clinical Case Studies in Long-Term Care Psychiatry
  • Online publication: 31 October 2024
  • Chapter DOI: https://doi.org/10.1017/9781108630344.025
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • “This Is Humiliating”
  • Matthew Gibfried, Saint Louis University School of Medicine, Missouri, George T. Grossberg, Saint Louis University School of Medicine, Missouri
  • Book: Clinical Case Studies in Long-Term Care Psychiatry
  • Online publication: 31 October 2024
  • Chapter DOI: https://doi.org/10.1017/9781108630344.025
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • “This Is Humiliating”
  • Matthew Gibfried, Saint Louis University School of Medicine, Missouri, George T. Grossberg, Saint Louis University School of Medicine, Missouri
  • Book: Clinical Case Studies in Long-Term Care Psychiatry
  • Online publication: 31 October 2024
  • Chapter DOI: https://doi.org/10.1017/9781108630344.025
Available formats
×